(1) If the result of an initial drug test is a positive result, as soon as practicable after the result is known, the approved tester must:
(a) allocate to the body sample a sample identifier; and
(b) divide the body sample into approximately equal lots to be known as Sample A and Sample B; and
(c) place Sample A and Sample B into separate specimen tubes; and
(d) place both tubes into a single container.
(2) In allocating the sample identifier under paragraph (1)(a), the approved tester must use the method specified in a legislative instrument made by CASA under regulation 99.150.
(3) The amount of body sample in Sample A and Sample B must be sufficient for a confirmatory drug test to be conducted.
(4) Immediately before the body sample is placed in them, the tubes must:
(a) be in the packages provided by the manufacturer; and
(b) not have been used for any purpose; and
(c) be in such a condition that they do not affect the quality of the body sample taken.
(5) As soon as practicable after placing Sample A and Sample B into separate specimen tubes, the approved tester must:
(a) securely seal each tube with tamper - evident seals; and
(b) label each tube with the following information:
(i) the tester's initials;
(ii) the sample identifier for the body sample;
(iii) information about whether the tube contains Sample A or Sample B.
(6) The approved tester must ask the donor to:
(a) witness the tester's actions under this regulation in respect of the body sample; and
(b) initial the tamper - evident seals on the tubes; and
(c) sign the notice given to the donor under regulation 99.175.
(7) If the donor refuses a request made by the approved tester
under subregulation (6), the tester must, in the notice given under
paragraph 99.170(5)(a), set out that fact.